Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instrument, Reagent, Consumables), Technology (qPCR, dPCR), Application (Oncology, Pathogen Detection, Research, Forensic), End User (Pharma, Academic, Hospitals, CRO) - Forecast to 2024

Real Time PCR and digital PCR are used for specific detection and quantification of nucleic acids. The adoption of these techniques helps to measure minor variants within the genetic material. Though, real time PCR is well established technique, digital PCR delivers an absolute measure of target nucleic acid molecules. Factors such as increasing incidence & prevalence of genetic & infectious diseases; technological advancement in PCR; and rising number of CRO, forensic, and other research laboratories are driving the growth in dPCR and qPCR market. Moreover, emerging opportunities from Asian countries and transition from plant to genome based drug discovery will provide high opportunities for this market in forecast period. On the other hand, technical limitations associated with PCR and high cost of PCR devices are expected to restrict the growth of this market.

Potential of Real Time PCR and Digital PCR Market                            

Recently, increasing number of viral diseases put pressure on healthcare sector. For instance, according to the Centers for Disease Control and Prevention (CDC) predictions, there were only 2 Powassan virus neuroinvasive disease cases reported for the year 2008 which has increased to 33 in 2017 in the U.S. Thus, to discover the drug or biomarker for these viral diseases, researchers are widely adopting digital PCR technique. Similarly, advancement in digital PCR techniques holds great promise in detection of rare cancer biomarkers. For instance, researchers are expected to use digital droplet PCR (ddPCR) along with molecular biology techniques to discover new cancer biomarkers. Thus, such a growing advancement and rising prevalence of diseases provide huge potential for adoption of PCR techniques.

                                                                 Click here to : Get Free Sample Pages of this Report

Detailed Potential Market Analysis

The dPCR and qPCR market is segmented by product (instruments, reagents & kits, consumables, and software & services), technology (qPCR, dPCR), application (clinical, research, and forensic), end user (pharmaceutical & biotechnology companies, hospitals and diagnostic labs, academic and research laboratories, clinical research organizations (CROs), and forensic laboratories) and geography.

Based on product, reagents and kits accounted for the largest share of dPCR and qPCR market in 2018 due to their repeated usage and rising procurement for various clinical, research, and other applications.

Based on technology, real time PCR commanded the largest share of dPCR and qPCR market in 2018. This is mainly due to increased adoption of qPCR over traditional PCR technology owing to its advantages such as fast start-up time, better temperature control, and real-time measurement. However, dPCR is expected to grow at a fastest CAGR within the forecast year due to growing preference for this technology in clinical research and drug development with absolute detection and reduced consumption of reagents.

On the basis of geographical analysis, North America including U.S. and Canada are anticipated to be the largest market due to increasing funding for qPCR and dPCR technologies, growing incidence & prevalence of infectious and genetic diseases, continuous reduction in gene sequencing cost, and presence of key players in the region. However, Asia Pacific region is expected to grow at a fastest CAGR due to rapidly developing economies, growing aging population coupled with rising incidence of genetic diseases, rise in government support for life science research, growing research & clinical trial outsourcing from the region, and increasing number of CROs.

Key Players dPCR & qPCR players

Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories Inc. (U.S.), QIAGEN N.V. (Netherlands), Takara Bio Inc. (Japan), bioMérieux S.A. (France), Agilent Technologies, Inc. (U.S.), Fluidigm Corporation (U.S.), Abbott Laboratories (U.S.), Merck KGaA (Germany), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), Promega Corporation (U.S.), Meridian Bioscience, Inc. (U.S.), and Analytik Jena AG (Germany) are some of the key players in this market. The report provides the information on dPCR market share & qPCR market share of the all key players operating in this market

Key questions answered in the report:

Growing penetration of digital PCR (dPCR) and real-time PCR (qPCR) in developing countries will propel the overall Digital PCR (dPCR) and Real-time PCR (qPCR) Market

• How does the adoption of digital PCR and real-time PCR in developed regions differ from developing countries like India and China?
• How is the competition between the major global and prominent local players in this market?
• Which are the high growth market segments in terms of product, technology, application, end users, and countries?

Pharmaceutical & biotechnology companies accounted for the largest share of the global digital PCR (dPCR) and real-time PCR (qPCR) market

• What factors contribute to the frequent usage of digital PCR and real-time PCR in pharmaceutical & biotechnology companies?
• Which region is expected to experience the fastest growth in the usage of digital PCR and real-time PCR products in pharmaceutical & biotechnology companies?
• How does the penetration of digital PCR and real-time PCR in pharmaceutical & biotechnology companies differ from other end users such as hospitals and diagnostic labs, academic and research laboratories, clinical research organizations (CROs), and forensic laboratories?

Digital PCR (dPCR) and real-time PCR (qPCR) market favours both larger and local manufacturers that compete in multiple segments

• Who are the top competitors in this market and what strategies do they employ to gain shares?
• What is driving growth and which market segments have the most potential for revenue expansion over the forecast period?
• What strategies should new companies looking to enter this market use to compete effectively?
• What are the major drivers, restraints, opportunities, and challenges in digital PCR (dPCR) and real-time PCR (qPCR) market?
• Who are the major players in various countries and what share of the market do they hold?
• What are the geographical trends and high growth regions/ countries?

Recent partnerships, acquisitions, and expansions have taken place in the global digital PCR (dPCR) and real-time PCR (qPCR) market

• Which companies have recently merged/acquired and how will these unions affect the competitive landscape of the digital PCR (dPCR) and real-time PCR (qPCR) market?
• What companies have created partnerships and how will these partnerships promote a competitive advantage?
• Who are the major players in the global digital PCR (dPCR) and real-time PCR (qPCR) market and what share of the market do they hold?
• What are the local emerging players in the global digital PCR (dPCR) and real-time PCR (qPCR) market and how do they compete with the global players?